In a mouse model of pulmonary hypertension, administration of pravastatin ameliorated hypoxia-induced pulmonary hypertension and was associated with decreased accumulation of bone marrow-derived progenitor cells in the pulmonary artery adventitia and reduced plasma levels of CXCL12 [10]. The gene discussed is CXCL12; the disease is pulmonary arterial hypertension.